Skip to content
★ Sign in to follow
AI

Akili, Inc. Stock: price and insider trades · United States

Akili, Inc.: what insiders have been doing

Akili, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for Akili, Inc. The previous disclosure was published on 8 July 2024.

The full history, which starts in 2021, counts no purchases against 4 sales.

This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
51
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€5,900
4 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2023

FY ended December 2023 · cache

Income statement
Revenue1.5M
Gross profit764.7k51% margin
Net income-53M-3545.5% margin
Last declaration on 8 July 2024
Declarations51 total
  • ●
    Related company / holdingExecutives
    0SEC
    12,527,477 sharesCommon StockSEC:0000950170-24-082232:0
  • ●
    10% OwnerExecutives
    0SEC
    3,773,000 sharesCommon StockSEC:0000950170-24-081902:1
  • ●
    10% OwnerExecutives
    0SEC
    1,900,000 sharesCommon StockSEC:0000950170-24-081902:2
  • ●
    Related company / holdingExecutives
    0SEC
    10,336,425 sharesCommon Stock, par value $0.0001SEC:0000950170-24-081811:0
  • ●
    Executives
    0SEC
    8,100,000 sharesCommon StockSEC:0000950170-24-081902:0
  • ●
    Chief Legal OfficerExecutives
    0SEC
    92,869 sharesCommon Stock, par value $0.0001SEC:0001562180-24-005425:1
  • ●
    President & CEOExecutives
    0SEC
    33,000 sharesCommon Stock, par value $0.0001SEC:0001562180-24-005428:1
  • ●
    DirectorExecutives
    0SEC
    99,548 sharesCommon Stock, par value $0.0001SEC:0001562180-24-005423:1
  • ●
    DirectorExecutives
    0SEC
    3,063,364 sharesCommon Stock, par value $0.0001SEC:0001562180-24-005422:1
  • ●
    DirectorExecutives
    0SEC
    1,089,314 sharesCommon Stock, par value $0.0001SEC:0001562180-24-005421:0
  • ●
    DirectorExecutives
    0SEC
    693,226 sharesCommon Stock, par value $0.0001SEC:0001562180-24-005422:0
  • ●
    DirectorExecutives
    0SEC
    48,690 sharesCommon Stock, par value $0.0001SEC:0001562180-24-005423:0
  • ●
    President & CEOExecutives
    0SEC
    7,657 sharesCommon Stock, par value $0.0001SEC:0001562180-24-005428:0
  • ●
    Chief Legal OfficerExecutives
    0SEC
    30,693 sharesCommon Stock, par value $0.0001SEC:0001562180-24-005425:0
  • ◆
    Chief Legal OfficerExecutives
    2,163 USD14SEC
    5,118 shares@ US$0.422730.0% of flowCommon StockSEC:0001562180-24-004957:0
  • ◆
    DirectorExecutives
    2,115 USD13SEC
    5,174 shares@ US$0.408815.9% of flowCommon StockSEC:0001562180-24-003853:0
  • ◆
    Chief Legal OfficerExecutives
    752 USD12SEC
    1,840 shares@ US$0.408810.6% of flowCommon StockSEC:0001562180-24-003854:0
  • ◆
    DirectorExecutives
    884 USD12SEC
    2,599 shares@ US$0.346.5% of flowCommon StockSEC:0001562180-24-002613:0
  • ◆
    President & CEOExecutives
    549 USD24SEC
    1,615 shares@ US$0.3422.9% of flowCommon StockSEC:0001562180-24-002612:0
  • ◆
    Chief Legal OfficerExecutives
    351 USD11SEC
    1,032 shares@ US$0.344.8% of flowCommon StockSEC:0001562180-24-002614:0
  • ◆
    Chief Legal OfficerExecutives
    0SEC
    69,750 sharesCommon StockSEC:0001562180-23-008254:0
  • ◆
    Chief Financial OfficerExecutives
    0SEC
    69,750 sharesCommon StockSEC:0001562180-23-008253:0
  • ◆
    Chief Legal OfficerExecutives
    721 USD12SEC
    1,840 shares@ US$0.391810.3% of flowCommon StockSEC:0001562180-23-007573:0
  • ◆
    DirectorExecutives
    2,091 USD13SEC
    5,337 shares@ US$0.391815.9% of flowCommon StockSEC:0001562180-23-007572:0
  • ◆
    Chief Financial OfficerExecutives
    380 USD21SEC
    969 shares@ US$0.391816.8% of flowCommon StockSEC:0001562180-23-007574:0

25 of 51 declarations

About Akili, Inc.

Akili, Inc. is a health technology company that develops therapeutic video games to treat cognitive disorders. It is listed on the NASDAQ under the ticker symbol AKLI.